44 related articles for article (PubMed ID: 11928806)
1. Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions.
Carriero MV; Franco P; Gargiulo L; Vocca I; Cito L; Fontana L; Iaccarino C; Del Pozzo G; Guardiola J; Stoppelli MP
Biol Chem; 2002 Jan; 383(1):107-13. PubMed ID: 11928806
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.
Chiaradonna F; Fontana L; Iavarone C; Carriero MV; Scholz G; Barone MV; Stoppelli MP
EMBO J; 1999 Jun; 18(11):3013-23. PubMed ID: 10357814
[TBL] [Abstract][Full Text] [Related]
3. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.
Carriero MV; Del Vecchio S; Capozzoli M; Franco P; Fontana L; Zannetti A; Botti G; D'Aiuto G; Salvatore M; Stoppelli MP
Cancer Res; 1999 Oct; 59(20):5307-14. PubMed ID: 10537314
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
[TBL] [Abstract][Full Text] [Related]
5. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
[TBL] [Abstract][Full Text] [Related]
6. Urokinase signal transduction and its role in cell migration.
Carlin SM; Resink TJ; Tamm M; Roth M
FASEB J; 2005 Feb; 19(2):195-202. PubMed ID: 15677342
[TBL] [Abstract][Full Text] [Related]
7. Vitronectin binding to urokinase receptor in human breast cancer.
Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M
Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
[TBL] [Abstract][Full Text] [Related]
9. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
12. Expression of the urokinase receptor regulates focal adhesion assembly and cell migration in adenoid cystic carcinoma cells.
Abu-Ali S; Sugiura T; Takahashi M; Shiratsuchi T; Ikari T; Seki K; Hiraki A; Matsuki R; Shirasuna K
J Cell Physiol; 2005 May; 203(2):410-9. PubMed ID: 15521066
[TBL] [Abstract][Full Text] [Related]
13. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways.
Degryse B; Orlando S; Resnati M; Rabbani SA; Blasi F
Oncogene; 2001 Apr; 20(16):2032-43. PubMed ID: 11360187
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
Nip J; Rabbani SA; Shibata HR; Brodt P
J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of alphavbeta5 integrin activation.
Vocca I; Franco P; Alfano D; Votta G; Carriero MV; Estrada Y; Caputi M; Netti PA; Ossowski L; Stoppelli MP
Int J Cancer; 2009 Jan; 124(2):316-25. PubMed ID: 18844213
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
18. Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression.
Silvestri I; Longanesi Cattani I; Franco P; Pirozzi G; Botti G; Stoppelli MP; Carriero MV
Int J Cancer; 2002 Dec; 102(6):562-71. PubMed ID: 12447996
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist.
Franco P; Massa O; Garcia-Rocha M; Chiaradonna F; Iaccarino C; Correas I; Mendez E; Avila J; Blasi F; Stoppelli MP
J Biol Chem; 1998 Oct; 273(42):27734-40. PubMed ID: 9765311
[TBL] [Abstract][Full Text] [Related]
20. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.
Degryse B; Resnati M; Rabbani SA; Villa A; Fazioli F; Blasi F
Blood; 1999 Jul; 94(2):649-62. PubMed ID: 10397732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
